Allianz Asset Management’s Heron Therapeutics HRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-155,085	Closed	-$887K	–	2318
2022 Q1	$887K	Sell	155,085 -60,559	-28%	-$443K	﹤0.01%	1902
2021 Q4	$1.97M	Buy	+215,644	New	+$2.2M	﹤0.01%	1614
2020 Q1	–	Sell	-91,948	Closed	-$2.16M	–	2598
2019 Q4	$2.16M	Sell	91,948 -45,260	-33%	-$1M	﹤0.01%	1830
2019 Q3	$2.58M	Sell	137,208 -30,745	-18%	-$566K	﹤0.01%	1725
2019 Q2	$3.12M	Sell	167,953 -950,032	-85%	-$19M	﹤0.01%	1707
2019 Q1	$27.3M	Buy	1,117,985 +51,722	+5%	+$1.35M	0.03%	632
2018 Q4	$27.5M	Sell	1,066,263 -821,128	-44%	-$22.6M	0.03%	577
2018 Q3	$59.7M	Buy	1,887,391 +1,721,947	+1,041%	+$64.1M	0.06%	380
2018 Q2	$6.43M	Buy	165,444 +57,518	+53%	+$1.83M	0.01%	1434
2018 Q1	$2.98M	Sell	107,926 -1,665	-2%	-$37.8K	﹤0.01%	1750
2017 Q4	$1.98M	Sell	109,591 -117	-0.1%	-$1.91K	﹤0.01%	2019
2017 Q3	$1.77M	Buy	109,708 +51	+0%	+$800	﹤0.01%	2050
2017 Q2	$1.52M	Buy	109,657 +16,429	+18%	+$238K	﹤0.01%	2079
2017 Q1	$1.41M	Sell	93,228 -300	-0.3%	-$4.15K	﹤0.01%	2122
2016 Q4	$1.23M	Sell	93,528 -74,441	-44%	-$1.17M	﹤0.01%	2146
2016 Q3	$2.88M	Sell	167,969 -46,922	-22%	-$871K	﹤0.01%	1844
2016 Q2	$3.88M	Sell	214,891 -257,787	-55%	-$5.03M	0.01%	1625
2016 Q1	$8.98M	Buy	472,678 +25,787	+6%	+$509K	0.01%	1181
2015 Q4	$12.2M	Buy	446,891 +289,936	+185%	+$7.75M	0.02%	974
2015 Q3	$3.83M	Sell	156,955 -282,185	-64%	-$9.4M	﹤0.01%	1384
2015 Q2	$13.7M	Sell	439,140 -515,640	-54%	-$9.7M	0.02%	960
2015 Q1	$13.9M	Buy	+954,780	New	+$10.8M	0.02%	823